Bio-Rad Laboratories, Inc. (BIO) vs Insulet Corp. (PODD)
PODD leads on 11 of 15 compared metrics.
A side-by-side comparison of Bio-Rad Laboratories, Inc. and Insulet Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 25, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BIO vs PODD
growth of $100 · last 19yBIO +319.9%PODD +863.8%PODD compounded faster
BIO PODD
BIO vs PODD: by the numbers
- •PODD is the larger company ($10.65B vs $8.06B market cap).
- •PODD trades at the lower earnings multiple (35.77 vs 49.14 P/E).
- •PODD converts more revenue to profit (10.44% vs 6.52% net margin).
- •PODD grew revenue faster over the past five years (24.79% vs -0.84% CAGR).
Which is better, BIO or PODD?
Metric tally: BIO 4 · PODD 11It depends on what you're optimizing for:
ValuePODD(lower P/E)
GrowthPODD(faster 5Y revenue CAGR)
QualityPODD(higher ROIC)
Metrics side by side
Valuation
| Metric | BIO | PODD |
|---|---|---|
| P/E ratio | 49.14 | 35.77● |
| Forward P/E | 29.93 | 18.96● |
| P/S ratio | 3.10● | 3.72 |
| P/B ratio | 1.17● | 8.29 |
| PEG ratio | — | 0.36 |
| EV / EBITDA | 18.97● | 19.59 |
| FCF yield | 4.44%● | 3.82% |
Profitability
| Metric | BIO | PODD |
|---|---|---|
| Gross margin | 51.87% | 71.01%● |
| Operating margin | 9.25% | 17.48%● |
| Net margin | 6.52% | 10.44%● |
| ROE | 2.46% | 23.25%● |
| ROIC | 2.04% | 13.62%● |
Growth (annualized)
| Metric | BIO | PODD |
|---|---|---|
| Revenue CAGR (5Y) | -0.84% | 24.79%● |
| EPS CAGR (5Y) | -26.27% | 99.91%● |
| FCF CAGR (5Y) | -7.57% | 79.41%● |
| Total return CAGR (5Y) | -13.99% | -11.19%● |
Frequently asked
- Which is better, BIO or PODD?
- It depends on your goal. value: PODD (lower P/E); growth: PODD (faster 5Y revenue CAGR); quality: PODD (higher ROIC). Across all compared metrics, PODD leads 11 to 4.
- Is BIO or PODD cheaper?
- On trailing earnings, PODD is cheaper: BIO trades at a 49.14 P/E and PODD at 35.77.
- Which has grown faster, BIO or PODD?
- Over the past five years, PODD grew revenue faster — BIO at a -0.84% CAGR versus PODD at 24.79%.
- Is BIO or PODD more profitable?
- PODD runs the higher net margin — BIO at 6.52% versus PODD at 10.44%.
- Which has been the better investment, BIO or PODD?
- Over the past 10-year, PODD delivered the higher annualized total return — BIO at 7.96% versus PODD at 18.34%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioInsulet P/E ratioBio-Rad Laboratories dividend yieldInsulet dividend yieldBio-Rad Laboratories ROEInsulet ROEBio-Rad Laboratories operating marginInsulet operating marginBio-Rad Laboratories revenue growthInsulet revenue growthBio-Rad Laboratories free cash flowInsulet free cash flow
Bio-Rad Laboratories & Insulet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 25, 2026.